NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054664

Registered date:14/06/2024

Clinical Validation Study of Plasma-based RAS Gene Mutation Testing using LS104R in Metastatic Colorectal Cancer

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedColorectal cancer
Date of first enrollment2023/07/27
Target sample size128
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomePositive Percent Agreement (PPA) and Negative Percent Agreement (NPA) of both KRAS and NRAS gene exon 2, 3 and 4 mutations between Test method and Reference method
Secondary Outcome1. Overall percent agreement (OPA) between Test method and Reference method 2. Positive predictive value (PPV) and negative predictive value (NPV) between Test method and Reference method 3. Codon-based concordance rate between Test method and Reference method in RAS mutation-positive cases 4. MAF correlation between Test method and Reference method in RAS mutation-positive cases

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaN/A

Related Information

Contact

public contact
Name Masahiro Nishida
Address 4-4-4 Takatsukadai, Nishi-ku, Kobe, 651-2271, Japan Japan 651-2271
Telephone 078-991-1911
E-mail Nishida.Masahiro@sysmex.co.jp
Affiliation Sysmex Corporation Medical & Scientific Affairs
scientific contact
Name Takayuki Yoshino
Address 6-5-1 Kashiwanoha, Kashiwa-shi Chiba, 277-8577 Japan Japan
Telephone 04-7133-1111
E-mail tyoshino@east.ncc.go.jp
Affiliation National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal Oncology